NICOLIN, ANGELO NICOLO'
NICOLIN, ANGELO NICOLO'
DIPARTIMENTO DI FARMACOLOGIA, CHEMIOTERAPIA E TOSSICOLOGIA MEDICA (attivo dal 01/01/1960 al 26/04/2012)
[The pharmacologic activity of 1(2-(p-chloro-alpha-phenylbenzyloxy)ethyl)piperidine (cloperastine)]
1983 G. Canti, P. Franco, A. Nicolin
A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines
1996 S. Capaccioli, A. Quattrone, N. Schiavone, A. Calastretti, E. Copreni, A. Bevilacqua, G. Canti, L. Gong, S. Morelli, A. Nicolin
A conserved AU-rich element in the 3' untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis
2000 N. Schiavone, P. Rosini, A. Quattrone, M. Donnini, A. Lapucci, L. Citti, A. Bevilacqua, A. Nicolin, S. Capaccioli
Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia
1974 A. Nicolin, G. Canti, A. Goldin
Alterazioni antigeniche indotte da dimetil-triazeno-carbossamide (DTIC) nella leucemia L1210. Attivita' citotossica in vitro di splenociti immuni.
1972 A. Nicolin, G. Canti, P. Franco, C. Riccardi
ANTISENSE OLIGONUCLEOTIDE BLOCKS PROGESTERONE-INDUCED LORDOSIS BEHAVIOR IN OVARIECTOMIZED RATS
1993 G. Pollio, P. Xue, M. Zanisi, A. Nicolin, A. Maggi
Antisense oligonucleotide drug design
2004 N. Schiavone, M. Donnini, A. Nicolin, S. Capaccioli
Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors
1998 G. Canti, A. Nicolin, R. Cubeddu, P. Taroni, G. Bandieramonte, G. Valentini
Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light
1994 G. Canti, D. Lattuada, A. Nicolin, P. Taroni, G. Valentini, R. Cubeddu
Apoptosis is associated with modifications of bcl-2 mRNA AU-binding proteins
2001 M. Donnini, A. Lapucci, L. Papucci, E. Witort, A. Tempestini, G. Brewer, A. Bevilacqua, A. Nicolin, S. Capaccioli, N. Schiavone
Assimilation of LDL by experimental tumours in mice
1989 P. Lombardi, G. Norata, F. M. Maggi, G. Canti, P. Franco, A. Nicolin, A. L. Catapano
AUF1 Is a bcl-2 A + U-rich element-binding protein involved in bcl-2 mRNA destabilization during apoptosis
2002 A. Lapucci, M. Donnini, L. Papucci, E. Witort, A. Tempestini, A. Bevilacqua, A. Nicolin, G. Brewer, N. Schiavone, S. Capaccioli
B cell lymphoma (Bcl)-2 protein is the major determinant in bcl-2 adenine-uridine-rich element turnover overcoming HuR activity
2009 L. Ghisolfi, A. Calastretti, S. Franzi, G. Canti, M. Donnini, S. Capaccioli, A. Nicolin, A. Bevilacqua
Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt
2004 L. Asnaghi, A.L. Calastretti, A.T. Bevilacqua, I. D’Agnano, G. Gatti, G. Canti, S. Capaccioli, A.N. Nicolin
Bcl-2 protein is required for the adenine/uridine-rich element (ARE)-dependent degradation of its own messenger
2003 A. Bevilacqua, M.C. Ceriani, G. Canti, L. Asnaghi, R. Gherzi, G. Brewer, L. Papucci, N. Schiavone, S. Capaccioli, A. Nicolin
BCL-2 regulation targeting the AU-rich domain
2000 A. Bevilacqua, M.C. Ceriani, N. Schiavone, A. Nicolin
Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles
2007 P. Bruno, A. Calastretti, M. Priulla, L. Asnaghi, F. Scarlatti, A. Nicolin, G. Canti
Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines
1981 A. Nicolin, G. Canti, O. Marelli, F. Veronese, A. Goldin
Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukiemia
2010 G. Canti, A.L. Calastretti, A.T. Bevilacqua, E. Reddi, G. Palumbo, A.N. Nicolin
Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase
2001 A. Calastretti, A. Bevilacqua, C. Ceriani, S. Viganò, P. Zancai, S. Capaccioli, A. Nicolin